Memorial Health System Expands Vascular Surgery Team with New Surgeon
November 30, 2024 - 15:12
MARIETTA — Memorial Health System has announced the addition of Dr. Albeir Mousa, a highly qualified vascular surgeon, to its team at Marietta Memorial Hospital. Dr. Mousa brings a wealth of experience and expertise, enhancing the capabilities of the vascular team at MHS. His arrival is expected to significantly improve the level of care available to patients in the region.
Dr. Mousa is known for his proficiency in innovative vascular technologies and research, which will be instrumental in optimizing patient outcomes. His commitment to providing the highest quality of care aligns with the mission of Memorial Health System to deliver exceptional healthcare services to the community.
As he begins seeing patients, Dr. Mousa is poised to make a positive impact on the local healthcare landscape, ensuring that individuals in need of vascular care have access to the latest advancements and treatments available. The integration of his skills into the MHS team marks a promising development for patient care in the area.
MORE NEWS
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...
July 20, 2026 - 11:31
Seven peptides are under review by an FDA panel this week. Here’s everything we knowA federal advisory committee is set to meet this week to evaluate seven peptide products, a move that could reshape how these compounds are made and prescribed in the United States. The panel,...